DiaSorin company profile

DIA · Borsa Italiana · EUR

Compare DiaSorin
€77.84Change from previous close: −1.99%Absolute change: −€1.58

Close · November 20, 2026

Company profile

DiaSorin has 3,212 employees and is headquartered in Saluggia, Italy.

With 3,212 employees and sales of 1.2 billion euros in the fiscal year ended December 2025, the company develops, makes and distributes diagnostic test kits for clinical laboratories. Its immunoassay menu covers infections, digestive disorders, hepatitis and retroviruses, hormones, metabolic conditions and tumor markers, run on its LIAISON instruments. Its molecular line includes a congenital cytomegalovirus kit that detects viral DNA in saliva and urine, a respiratory panel, a yeast blood culture assay and the xMAP multiplexing platform. Products are sold in Europe, North America and other international markets.

Revenue rose 0.8% from the previous year, and net profit stood at 155.6 million euros in the same fiscal year. Founded in 1968 and headquartered in Saluggia, Italy, the group reports 3,212 employees.

Company facts

Industry
Diagnostics & Research
Country
Italy
Headquarters
Via Crescentino snc, 13040, Saluggia
Employees
3,212
Chief executive
Carlo Rosa
Founded
1968
Fiscal year
January - December
Listing
DIA · Borsa Italiana
Currency
EUR
ISIN
IT0003492391

DiaSorin and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
DiaSorinDIAItaly$4.21B3,21222.3%28.6
QiagenQIAGermany$10.23B5,40026.7%28.5
bioMérieuxBIMFrance$11.82B14,56216.0%23.4
DiagnostykaDIAPoland$1.27B8,64514.9%20.2
Eurofins ScientificERFFrance$16.03B65,00014.1%29.6
Lonza GroupLONNSwitzerland$54.2B20,14123.5%43.2

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare DiaSorin with its competitors